TissuePrint
Commercial- Indications
- General tissue engineering
Company intelligence / Profile preview
Axolotl Biosciences develops proprietary xeno-free bioinks designed to support high cell viability during the printing of human neural tissues. Their technology enables researchers to create advanced humanized tissue models—such as mini-brains derived from patient cells—for use in disease modeling (e.g., Alzheimer’s), drug screening, toxicity testing, developmental biology studies, and regenerative medicine research. Early results using their printed neural tissues have shown promising recapitulation of key neurodegenerative disease markers such as amyloid beta and tau proteins.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Axolotl Biosciences.